Neuroone Medical Technologies (NMTC) Corporate presentation summary

Vision and mission

• Aims to transform the lives of patients with neurological diseases and chronic pain by providing better solutions.

• Focuses on innovative treatments that can significantly improve patient outcomes, such as reducing seizures.

Technology and product platform

• Proprietary flexible thin film electrode technology enables both diagnostic and therapeutic applications.

• Four FDA 510(k) clearances for products addressing epilepsy, trigeminal neuralgia, and chronic pain.

• Only FDA-cleared device using the same SEEG electrode for diagnostics and therapy.

• Product portfolio includes Evo Cortical and SEEG electrodes, OneRF Ablation System, and drug delivery systems.

Strategic partnerships

• Partnership with Zimmer Biomet includes licensing, distribution, and integration with robotic neurosurgery platforms.

• Mayo Clinic collaboration for pre-clinical and clinical research, with key advisory board members from Mayo.